Wedge Capital Management L L P NC Sells 21,330 Shares of GE HealthCare Technologies Inc. $GEHC

Wedge Capital Management L L P NC reduced its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 6.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 336,308 shares of the company’s stock after selling 21,330 shares during the period. Wedge Capital Management L L P NC owned approximately 0.07% of GE HealthCare Technologies worth $27,584,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently modified their holdings of the company. Empowered Funds LLC boosted its position in GE HealthCare Technologies by 6.1% in the first quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock worth $2,328,000 after purchasing an additional 1,665 shares during the last quarter. Acadian Asset Management LLC bought a new position in shares of GE HealthCare Technologies in the 1st quarter worth approximately $259,000. Global Retirement Partners LLC purchased a new position in shares of GE HealthCare Technologies in the second quarter worth approximately $755,000. CreativeOne Wealth LLC boosted its holdings in shares of GE HealthCare Technologies by 5.2% in the second quarter. CreativeOne Wealth LLC now owns 3,094 shares of the company’s stock worth $229,000 after buying an additional 152 shares during the last quarter. Finally, Steward Partners Investment Advisory LLC grew its position in GE HealthCare Technologies by 4.9% during the second quarter. Steward Partners Investment Advisory LLC now owns 11,642 shares of the company’s stock valued at $862,000 after buying an additional 549 shares during the period. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

GEHC opened at $69.23 on Friday. The company has a 50 day simple moving average of $77.91 and a two-hundred day simple moving average of $78.26. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13. The firm has a market cap of $31.59 billion, a P/E ratio of 15.18, a PEG ratio of 1.57 and a beta of 1.03. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, beating analysts’ consensus estimates of $1.40 by $0.04. The company had revenue of $5.70 billion for the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. GE HealthCare Technologies’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Equities analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be paid a $0.035 dividend. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is 3.07%.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. Wells Fargo & Company increased their price target on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. Citigroup cut their price objective on shares of GE HealthCare Technologies from $88.00 to $84.00 and set a “neutral” rating for the company in a research report on Wednesday, March 11th. Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Monday, December 29th. BTIG Research reiterated a “buy” rating and set a $91.00 target price on shares of GE HealthCare Technologies in a research report on Thursday, March 19th. Finally, Stifel Nicolaus boosted their price target on GE HealthCare Technologies from $95.00 to $98.00 and gave the company a “buy” rating in a report on Wednesday, February 4th. Seven investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $92.17.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.